US$ 22.02
glutathione in dementia Elevation of as a Therapeutic Strategy Alzheimer Disease Neuronal glutathione loss leads to
Description
Lee and staff

Despite the early termination of the trial, it is interesting to note that 13 of 140 patients had a median duration of response of 10.2 months, indicating that these patients benefited from combination therapy and that exploring the mechanisms of this benefit should be the focus of future research

You can book your appointment online at complexions.com/wellness or call one of our locations directly

2016;16((Suppl

doi 10.1016/j.jhep.2023.01.024
